Drug Targeting Organ-Specific Strategies

252 9 Tumour Vasculature Targeting
[10] Brown LF, Detmar M, Claffey K, Nagy JA, Feng D, Dvorak AM, Dvorak HF, EXS 1997, 79,
233–269.
[11] Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R, J. Clin. Invest.
1997, 99, 2625–2634.
[12] Dvorak HF, Galli SJ, Dvorak AM, Hum. Pathol. 1986, 17, 122–137.
[13] Gupta K, Kshirsagar S, Li W, Gui L, Ramakrishnan S, Gupta P, Law PY, Hebbel RP, Exp. Cell.
Res. 1999, 247, 495–504.
[14] Ferrara N, Keyt B, EXS 1997, 79, 209–232.
[15] Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M, Cell 1998, 92, 735––745.
[16] Kawasaki T, Kitsukawa T, Bekku Y, Matsuda Y, Sanbo M, Yagi T, Fujisawa H, Development
1999, 126, 4895–4902.
[17] Klein S, Roghani M, Rifkin DB, EXS 1997, 79, 159–192.
[18] Gleizes PE, Rifkin DB, Pathol. Biol. 1999, 47, 322–329.
[19] Miao HQ, Ishai Michaeli R, Atzmon R, Peretz T, Vlodavsky I, J. Biol. Chem. 1996, 271,
4879–4886.
[20] Czubayko F, Liaudet-Coopman ED, Aigner A, Tuveson AT, Berchem GJ, Wellstein A, Nature
Med. 1997, 3, 1137–1140.
[21] Rak J, Kerbel RS, Nature Med. 1997, 3, 1083–1084.
[22] Varner JA, EXS 1997, 79, 361–390.
[23] Aplin AE, Howe A, Alahari SK, Juliano RL, Pharmacol. Rev 1998, 50, 197–263.
[24] Frisch SM, Ruoslahti E, Curr. Opin. Cell Biol. 1997, 9, 701–706.
[25] Howe A, Aplin AE, Alahari SK, Juliano RL, Curr. Opin. Cell Biol. 1998, 10, 220–231.
[26] Cheresh DA, Adv. Molec. Cell Biol. 1993, 6, 225–252.
[27] Brooks PC, Clark RA, Cheresh DA, Science 1994, 264, 569–571.
[28] Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA, Science 1995, 270,
1500–1502.
[29] DiPietro LA, EXS 1997, 79, 295–314.
[30] Grant DS, Kleinman HK, EXS 1997, 79, 317–333.
[31] Jendraschak E, Sage EH, Semin. Cancer Biol. 1996, 7, 139–146.
[32] Tremble PM, Lane TF, Sage EH, Werb Z, J. Cell Biol. 1993, 121, 1433–1444.
[33] Hasselaar P, Loskutoff DJ, Sawdey M, Sage EH, J. Biol. Chem. 1991, 266, 13178–13184.
[34] Hirschi KK, D’Amore PA, EXS 1997, 79, 419–428.
[35] Crocker DJ, Murad TM, Geer JC, Exp. Mol. Pathol. 1970, 13, 51–65.
[36] Kanda S, Landgren E, Ljungstrom M, Claesson-Welsh L Cell Growth Differ. 1996, 7, 383–395.
[37] Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ, J. Invest. Dermatol.
1992, 99, 683–690.
[38] Edgell CJ, McDonald CC, Graham JB, Proc. Natl Acad. Sci. USA 1983, 80, 3734–3737.
[39] Griffioen AW, Damen CA, Martinotti S, Blijham GH, Groenewegen G, Cancer Res. 1996, 56,
1111–1117.
[40] van Leeuwen EBM, Veenstra R, van Wijk R, Molema G, Hoekstra A, Ruiters MHJ, van der Meer
J, Blood Coagul. Fibrinol. 2000, 11, 15–25.
[41] Gupta SK, Singh JP, J. Cell Biol. 1994, 127, 1121–1127.
[42] Relou IAM, Damen CA, van der Schaft DWJ, Groenewegen GG, Griffioen AW, Tissue Cell
1998, 30, 525–530.
[43] Tsukada T, Kubota A, Ueda M, Amano J, Shimokado K, Numano F, Jpn. Circ. J. 1991, 55,
996–1002.
[44] Barrett TL, Smith KJ, Williams J, Corner SW, Hodge JJ, Skelton HG, Mod. Pathol. 1999, 12,
450–455.
[45] Allen RT, Hunter WJ, III, Agrawal DK, J. Pharmacol. Toxicol. Methods 1997, 37, 215–228.
[46] Ruegg C, Yilmaz A, Bieler G, Bamat J, Chaubert P, Lejeune FJ, Nature Med. 1998, 4, 408–414.
[47] Schraa AJ, Kok RJ, van Veen-Hof IH, Moorlag H, Meijer DKF, de Leij LFMH, Molema G, International
Meeting on Angiogenesis, Amsterdam April 27–29 2000.
[48] Glaser BM, D’Amore PA, Seppa H, Seppa S, Schiffmann E, Nature 1980, 288, 483–484.
[49] Sholley MM, Gimbrone Jr MA, Cotran RS, Lab. Invest. 1977, 36, 18–25.
[50] Barendsz-Janson AF, Griffioen AW, Muller AD, van Dam-Mieras MCE, Hillen HFP, J. Vasc.
Res. 1998, 35, 109–114.
[51] Vailhe B, Ronot X, Tracqui P, Usson Y, Tranqui L, In Vitro Cell Dev. Biol. Anim. 1997, 33,
763–773.
[52] Grant DS, Tashiro K, Segui Real B, Yamada Y, Martin GR, Kleinman HK, Cell 1989, 58, 933–943.